| Mon, Nov 2, 2009 | | • | Amylin Makes Obesity Drug Deal: BioBuzz
at TheStreet.com (Mon, Nov 2)
| | • | Amylin Strikes First With Obesity Drug Deal
at TheStreet.com (Mon, Nov 2)
| | • | Amylin Strikes First With Obesity Drug Deal: BioBuzz
at TheStreet.com (Mon, Nov 2)
| | • | [video] Amylin CEO on Diabetes & Diet Drugs
at CNBC (Mon, Nov 2)
| | • | [video] Biopharma Barrage
at CNBC (Mon, Nov 2)
| | Sun, Nov 1, 2009 | | • | Amylin Pharmaceuticals and Takeda Enter into Worldwide Agreement to Co-Develop and Commercialize Compounds for Obesity
PR Newswire (Sun, Nov 1)
| | Fri, Oct 30, 2009 | | • | BYETTA Approved for Expanded Use as First-Line Treatment for Type 2 Diabetes
PR Newswire (Fri, Oct 30)
| | • | Biotech Stocks: Drug stocks slip; Ipsen gains for second day
at MarketWatch (Fri, Oct 30)
| | • | Biotech Stocks: Drug stocks inch up; Ipsen gains for second day
at MarketWatch (Fri, Oct 30)
| | Wed, Oct 28, 2009 | | • | Top-Rated Stocks That Treat Shareholders Right
at Motley Fool (Wed, Oct 28)
| | Fri, Oct 23, 2009 | | • | Merck-Schering Doesn't Look So Good
at Motley Fool (Fri, Oct 23)
| | • | Global Healthcare Companies Investor 100% Overweighted To Biotech As Wave Of Acquisitions By Large Pharma Picks Up Pace
Wall Street Transcript (Fri, Oct 23)
| | Thu, Oct 22, 2009 | | • | Novo Nordisk Diabetes Drug May Aid Weight Loss
at CNBC (Thu, Oct 22)
| | • | Amylin Pharmaceuticals to Present at the 4th Annual BIOCOM Investor Conference
PR Newswire (Thu, Oct 22)
| | Tue, Oct 20, 2009 | | • | Earnings roundup: Sallie Mae, Cymer
AP (Tue, Oct 20)
| | • | Amylin 3Q profit narrows on lower costs
AP (Tue, Oct 20)
| | • | AMYLIN PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
EDGAR Online (Tue, Oct 20)
| | • | Amylin Pharmaceuticals Reports Third Quarter Financial Results
PR Newswire (Tue, Oct 20)
| | • | 5 Stocks Approaching Greatness
at Motley Fool (Tue, Oct 20)
| | • | Biotech Mergers And Acquisitions Will Accelerate According To Wedbush Morgan Expert Analyst As More Expensive Phase III Trials Force Small Biotech Companies Into Large Pharma Distribution And Finance Organizations
Wall Street Transcript (Tue, Oct 20)
| | • | "Best In Class" Formulation Of Fentanyl Seen As Breakthrough Treatment By Ladenburg Thalmann Analyst
Wall Street Transcript (Tue, Oct 20)
| | Mon, Oct 19, 2009 | | • | Amylin Pharmaceuticals Highlights New Data Supporting Therapeutic Potential of Obesity Pipeline at Obesity 2009
PR Newswire (Mon, Oct 19)
| | • | [$$] OSI, Huron Among Galleon Holdings
at The Wall Street Journal Online (Mon, Oct 19)
| | Tue, Oct 13, 2009 | | • | Amylin Pharmaceuticals to Webcast Third Quarter Results
PR Newswire (Tue, Oct 13)
| | Wed, Oct 7, 2009 | | • | StockPreacher.com Issues Trading Outlook for Hemispherx BioPharma Inc.
GlobeNewswire (Wed, Oct 7)
|
Add AMLN News to My Yahoo!:
 
| |
|
0.02% Nasdaq 0.00%
Headlines
